Your browser is no longer supported. Please, upgrade your browser.
DPLO Diplomat Pharmacy, Inc. daily Stock Chart
DPLO [NYSE]
Diplomat Pharmacy, Inc.
Index- P/E60.47 EPS (ttm)0.25 Insider Own0.20% Shs Outstand64.88M Perf Week-15.98%
Market Cap992.66M Forward P/E20.26 EPS next Y0.76 Insider Trans0.00% Shs Float47.07M Perf Month-12.47%
Income17.20M PEG4.20 EPS next Q0.15 Inst Own73.60% Short Float17.26% Perf Quarter-0.46%
Sales4.49B P/S0.22 EPS this Y1.30% Inst Trans15.50% Short Ratio11.94 Perf Half Y17.69%
Book/sh9.29 P/B1.65 EPS next Y15.62% ROA1.50% Target Price17.82 Perf Year-52.28%
Cash/sh0.26 P/C59.80 EPS next 5Y14.40% ROE2.80% 52W Range12.25 - 38.94 Perf YTD21.43%
Dividend- P/FCF14.97 EPS past 5Y18.00% ROI4.70% 52W High-60.71% Beta-
Dividend %- Quick Ratio0.80 Sales past 5Y41.70% Gross Margin7.40% 52W Low24.90% ATR0.77
Employees1737 Current Ratio1.40 Sales Q/Q8.30% Oper. Margin0.70% RSI (14)31.09 Volatility7.70% 4.01%
OptionableYes Debt/Eq0.22 EPS Q/Q-71.70% Profit Margin0.40% Rel Volume3.18 Prev Close16.51
ShortableYes LT Debt/Eq0.20 EarningsAug 07 AMC Payout0.00% Avg Volume680.61K Price15.30
Recom2.70 SMA20-15.45% SMA50-10.90% SMA200-13.35% Volume2,164,940 Change-7.33%
May-16-17Reiterated Mizuho Neutral $17 → $19
Nov-23-16Downgrade Credit Suisse Neutral → Underperform
Nov-03-16Reiterated Mizuho Neutral $39 → $17
Nov-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Nov-03-16Downgrade Avondale Mkt Outperform → Mkt Perform
Aug-10-16Reiterated Mizuho Neutral $33 → $39
Aug-10-16Reiterated Leerink Partners Outperform $36 → $38
Jun-07-16Resumed BofA/Merrill Neutral
May-11-16Reiterated Mizuho Neutral $30 → $33
Apr-19-16Initiated Avondale Mkt Outperform $38
Mar-16-16Initiated Credit Suisse Neutral
Mar-01-16Downgrade Mizuho Buy → Neutral $30
Oct-21-15Reiterated Mizuho Buy $53 → $44
Oct-14-15Upgrade BofA/Merrill Underperform → Neutral
Oct-02-15Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-04-15Reiterated Leerink Partners Outperform $40 → $55
Jul-16-15Initiated BofA/Merrill Underperform
Jul-09-15Resumed Morgan Stanley Overweight $41 → $56
Jun-29-15Initiated Mizuho Buy $53
May-27-15Initiated Raymond James Outperform $43
Jun-27-17 08:53AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bearish Manner : DPLO-US : June 27, 2017 Capital Cube -7.33%
Jun-26-17 06:30PM  Here's Why Diplomat Pharmacy Inc. Shares Are Down as Much as 13% Motley Fool -10.17%
Jun-16-17 03:40PM  ETFs with exposure to Diplomat Pharmacy, Inc. : June 16, 2017 Capital Cube
Jun-15-17 04:23PM  3 Healthcare Stocks for Ambitious Investors Motley Fool
Jun-08-17 04:30PM  Jeff Park Elected to Diplomat Board of Directors PR Newswire
Jun-06-17 04:30PM  Diplomat Specialty Infusion Group Now Providing Parenteral Nutrition Therapies in Iowa PR Newswire
Jun-05-17 04:30PM  Diplomat Specialty Infusion Group Cincinnati Named Top Workplaces PR Newswire
Jun-02-17 02:02PM  ETFs with exposure to Diplomat Pharmacy, Inc. : June 2, 2017 Capital Cube
May-25-17 04:30PM  Diplomat to Dispense KEVZARA® for Treatment of Rheumatoid Arthritis PR Newswire
May-24-17 04:30PM  Diplomat Recognized as Economic Bright Spot by Corp! Magazine PR Newswire
May-23-17 08:05AM  Diplomat Partners With Medication Adherence Company SMRxT PR Newswire
May-22-17 03:00PM  Diplomat to Host Analyst and Investor Day on June 27, 2017 PR Newswire
01:34PM  ETFs with exposure to Diplomat Pharmacy, Inc. : May 22, 2017 Capital Cube
May-19-17 10:12AM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-18-17 04:30PM  Diplomat Now Dispensing RYDAPT® (Midostaurin) for Acute Myeloid Leukemia PR Newswire
May-13-17 01:15PM  Edited Transcript of DPLO earnings conference call or presentation 8-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-09-17 08:20PM  Edited Transcript of DPLO earnings conference call or presentation 8-May-17 9:00pm GMT Thomson Reuters StreetEvents +9.25%
03:29PM  Here's Why Diplomat Pharmacy Inc. Is Rising Today Motley Fool
May-08-17 07:28PM  Diplomat Pharmacy, Inc. Q1 Earnings Suffer From Hepatitis C Headwinds and Higher DIR Fees Motley Fool
04:59PM  Diplomat Pharmaceuticals posts 1Q profit Associated Press
04:20PM  Diplomat Announces 1st Quarter Financial Results PR Newswire
04:10PM  Diplomat Acquires WRB Communications PR Newswire
12:19PM  5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More TheStreet.com
May-03-17 02:00PM  Diplomat to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference PR Newswire
Apr-19-17 05:08PM  Diplomat Will Dispense ZEJULA to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PR Newswire
02:59PM  Diplomat Pharmacy, Inc. Value Analysis (NYSE:DPLO) : April 19, 2017 Capital Cube
Apr-18-17 08:30AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bullish Manner : DPLO-US : April 18, 2017 Capital Cube
Apr-17-17 11:00AM  Diplomat to Release First Quarter 2017 Operating Results and Host Conference Call on Monday, May 8, 2017 PR Newswire
Apr-13-17 05:10PM  Diplomat Promotes Executive Jennifer Cretu PR Newswire
Apr-12-17 04:30PM  Diplomat Partners With Corizon Health to Dispense Specialty Drugs PR Newswire
Apr-11-17 08:00AM  Diplomat Appoints New Chief Financial Officer PR Newswire
Apr-06-17 04:30PM  Dr. Regina Benjamin Appointed to Diplomat's Board of Directors PR Newswire
Apr-05-17 04:38PM  ETFs with exposure to Diplomat Pharmacy, Inc. : April 5, 2017 Capital Cube
08:22AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bearish Manner : DPLO-US : April 5, 2017 Capital Cube
Apr-02-17 02:01PM  3 Top Specialty Pharma Stocks to Buy in 2017 Motley Fool
Mar-29-17 04:30PM  Diplomat Will Dispense OCREVUS to Treat Multiple Sclerosis PR Newswire
Mar-28-17 04:33PM  Diplomat to Dispense DUPIXENT® to Treat Atopic Dermatitis PR Newswire
Mar-16-17 04:30PM  Diplomat to Dispense KISQALI® for Metastatic Breast Cancer PR Newswire
Mar-14-17 01:04PM  DIPLOMAT PHARMACY, INC. Financials
Mar-08-17 05:22PM  DIPLOMAT PHARMACY, INC. Files SEC form 10-K, Annual Report
Mar-06-17 08:00AM  Diplomat to Dispense XERMELO for Patients With Carcinoid Syndrome Diarrhea PR Newswire
Mar-03-17 12:24PM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Capital Cube
Mar-02-17 02:04PM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
08:00AM  Diplomat Dispensing REVLIMID® for Multiple Myeloma Maintenance Therapy Following Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT) PR Newswire
Mar-01-17 04:00PM  Diplomat Pharmacy's Shares Are Soaring Today -- But Why? Motley Fool +10.11%
03:55AM  Edited Transcript of DPLO earnings conference call or presentation 28-Feb-17 10:00pm GMT
Feb-28-17 07:02PM  Diplomat Pharmacy, Inc. Q4 Earnings Hurt by Hep-C Headwinds at Motley Fool -5.97%
06:21PM  DIPLOMAT PHARMACY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
05:03PM  Diplomat Pharmaceuticals posts 4Q loss
04:15PM  Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance PR Newswire
07:07AM  Q4 2016 Diplomat Pharmacy Inc Earnings Release - After Market Close
Feb-27-17 01:14PM  5 Earnings Short-Squeeze Plays to Boost Your Returns
Feb-21-17 05:47PM  Meridian Growth Fund 4th Quarter Commentary
02:00PM  Diplomat to Participate in Upcoming Investor Conferences PR Newswire
09:30AM  Zacks.com featured highlights: American Axle & Manufacturing Holdings, AmerisourceBergen, Basic Energy Services, Diplomat Pharmacy and California Resources
Feb-17-17 07:57AM  5 Stocks in Favor With Brokers Right Now
Feb-14-17 04:30PM  Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director PR Newswire
Feb-07-17 02:00PM  Diplomat to Release Fourth Quarter and Full Year 2016 Operating Results and Host Conference Call on Tuesday, February 28, 2017 PR Newswire
Feb-06-17 12:00PM  Bullish and Bearish Reversals for the Week
Feb-03-17 08:40AM  Diplomat Pharmacy (DPLO) Catches Eye: Stock Jumps 9.4%
Feb-01-17 04:30PM  Diplomat Completes Acquisition of Affinity Biotech PR Newswire
Jan-26-17 07:44AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bullish Manner : DPLO-US : January 26, 2017
Jan-24-17 04:30PM  Diplomat Publishes Report on Specialty Drug Approvals PR Newswire
Jan-18-17 01:45PM  Diplomat Pharmacy, Inc. Value Analysis (NYSE:DPLO) : January 18, 2017
Jan-17-17 11:36AM  ETFs with exposure to Diplomat Pharmacy, Inc. : January 17, 2017
Jan-16-17 07:37AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bullish Manner : DPLO-US : January 16, 2017
Jan-13-17 02:35PM  Hurry! These 5 Stocks Are About to Break Out Explosively
Jan-09-17 04:04PM  DryShips, Stage Stores Plunge into Mondays 52-Week Low Club -5.52%
10:12AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Diplomat Pharmacy, Inc. (DPLO) and Lead Plaintiff Deadline - January 9, 2017 Accesswire
07:57AM  DIPLOMAT PHARMACY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
06:00AM  Diplomat Provides 2016 Financial Guidance Update PR Newswire
Jan-06-17 11:27AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Diplomat Pharmacy, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2017 DPLO GlobeNewswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Diplomat Pharmacy, Inc. (DPLO) and Lead Plaintiff Deadline - January 9, 2017 GlobeNewswire
07:17AM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
Jan-05-17 01:56PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO PR Newswire
Jan-04-17 10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Diplomat Pharmacy, Inc. (DPLO) and Lead Plaintiff Deadline - January 9, 2017 Accesswire +7.64%
Jan-03-17 03:28PM  GPM Reminds Investors of the January 9 Deadline in the Class Action Lawsuit Against Diplomat Pharmacy, Inc. Business Wire
11:16AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Diplomat Pharmacy, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2017 Business Wire
Dec-29-16 11:30AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  January 9 Deadline Alert: Law Offices of Howard G. Smith Reminds Diplomat Pharmacy, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourage Investors to Contact the Firm Business Wire
Dec-28-16 11:12AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:09AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Diplomat Pharmacy, Inc. (DPLO) and Lead Plaintiff Deadline - January 9, 2017 Accesswire
Dec-27-16 02:10PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:03PM  DPLO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Diplomat Pharmacy, Inc. and a Lead Plaintiff Deadline of January 9, 2017 Business Wire
Dec-23-16 12:40PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:22AM  Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. Business Wire
Dec-21-16 08:16PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
05:19PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:59PM  DPLO NOTICE: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important January 9 Deadline in Class Action - DPLO GlobeNewswire
11:00AM  DPLO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Diplomat Pharmacy, Inc. and a Lead Plaintiff Deadline of January 9, 2017 PR Newswire
Dec-20-16 02:20PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Diplomat Pharmacy, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit DPLO GlobeNewswire
11:07AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:09AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Diplomat Pharmacy, Inc. (DPLO) and Lead Plaintiff Deadline - January 9, 2017 Accesswire
Dec-19-16 02:00PM  Diplomat to Participate in the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-16-16 12:33PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
09:40AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Diplomat Pharmacy, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2017 DPLO Business Wire
Dec-14-16 01:10PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:51AM  DPLO Alert: The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Diplomat Pharmacy, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
11:46AM  Is Diplomat Pharmacy Inc (DPLO) Going to Burn These Hedge Funds? at Insider Monkey
Dec-13-16 12:38PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company's primary focus is on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. Diplomat Pharmacy, Inc. has 19 pharmacy locations in Arizona, California, Connecticut, Florida, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, North Carolina, Ohio, Pennsylvania, and Texas. The company was founded in 1975 and is headquartered in Flint, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaddis Atheer AEVP of Sales & Strategic AlignSep 15Option Exercise3.0720,00061,40020,000Sep 16 04:42 PM
Kaddis Atheer AEVP of Sales & Strategic AlignSep 15Sale30.1220,000602,3580Sep 16 04:42 PM
Kaddis Atheer AEVP of Sales & Strategic AlignAug 01Option Exercise3.0712,32537,83812,325Aug 02 04:32 PM
Kaddis Atheer AEVP of Sales & Strategic AlignAug 01Sale35.7612,325440,7940Aug 02 04:32 PM
Kaddis Atheer AEVP of Sales & Strategic AlignJul 01Option Exercise3.0712,32537,83812,325Jul 05 04:22 PM
Kaddis Atheer AEVP of Sales & Strategic AlignJul 01Sale35.0412,325431,8830Jul 05 04:22 PM